These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Hyperprolactinaemia and bone mineral density]. Kostrzak A; Męczekalski B Pol Merkur Lekarski; 2015 Aug; 39(230):122-5. PubMed ID: 26319389 [TBL] [Abstract][Full Text] [Related]
35. Polycystic ovary syndrome or hyperprolactinaemia: a study of mild hyperprolactinaemia. Su HW; Chen CM; Chou SY; Liang SJ; Hsu CS; Hsu MI Gynecol Endocrinol; 2011 Jan; 27(1):55-62. PubMed ID: 20504100 [TBL] [Abstract][Full Text] [Related]
36. [Hyperprolactinemia: from diagnosis to treatment]. Rosato F; Garofalo P Minerva Pediatr; 2002 Dec; 54(6):547-52. PubMed ID: 12388943 [TBL] [Abstract][Full Text] [Related]
37. Diagnosis and drug therapy of prolactinoma. Ciccarelli E; Camanni F Drugs; 1996 Jun; 51(6):954-65. PubMed ID: 8736617 [TBL] [Abstract][Full Text] [Related]
38. [Proceedings of seminar on hyperprolactinemia and dysfunctional uterine bleeding]. Yu Q; Zhen JR; Chen GA Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):244-6. PubMed ID: 18843960 [No Abstract] [Full Text] [Related]
39. Clinical and diagnostic characteristics of hyperprolactinemia in childhood and adolescence. Catli G; Abaci A; Bober E; Büyükgebiz A J Pediatr Endocrinol Metab; 2013; 26(1-2):1-11. PubMed ID: 23327784 [TBL] [Abstract][Full Text] [Related]
40. Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management. Haddad PM; Wieck A Drugs; 2004; 64(20):2291-314. PubMed ID: 15456328 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]